Skip to main content
. 2020 Sep 22;15(9):e0239401. doi: 10.1371/journal.pone.0239401

Table 3. Predictors of death or intubation: Final models.

Variable HR (95%CI) p
WHOLE COHORT (n = 242)
Week-2-MP 0.33 (0.13–0.84) 0.020
Non-pulse glucocorticoids 3.87 (1.87–8.02) <0.001
SpO2/FiO2 0.92 (0.89–0.94) <0.001
CURB65
 Low risk Reference
 Intermediate risk 1.93 (0.83–4.45) 0.125
 High risk 3.65 (1.48–9.02) 0.005
PATIENTS WITH SatO2/FiO2 ≤353 (n = 122)
Week-2-MP 0.34 (0.12–0.94) 0.038
Non-pulse glucocorticoids 3.16 (1.36–7.37) 0.008
SpO2/FiO2* 0.88 (0.83-0-93) <0.001
CURB65
 Low risk Reference
 Intermediate risk 1.78 (0.69–4.57) 0.234
 High risk 3.94 (1.44–10.78) 0.008

Week-2-MP: methyl-prednisolone pulses in week 2. HR: hazard ratio; CI: confidence interval.

*HR for SpO2/FiO2 is change in hazard for each increase of 10 units in its value.